These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 28363855)

  • 1. Planetary ball milling and supercritical fluid technology as a way to enhance dissolution of bicalutamide.
    Szafraniec J; Antosik A; Knapik-Kowalczuk J; Kurek M; Syrek K; Chmiel K; Paluch M; Jachowicz R
    Int J Pharm; 2017 Nov; 533(2):470-479. PubMed ID: 28363855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced dissolution of solid dispersions containing bicalutamide subjected to mechanical stress.
    Szafraniec J; Antosik A; Knapik-Kowalczuk J; Chmiel K; Kurek M; Gawlak K; Paluch M; Jachowicz R
    Int J Pharm; 2018 May; 542(1-2):18-26. PubMed ID: 29481948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tabletting solid dispersions of bicalutamide prepared using ball-milling or supercritical carbon dioxide: the interrelationship between phase transition and
    Antosik-Rogóż A; Szafraniec-Szczęsny J; Gawlak K; Knapik-Kowalczuk J; Paluch M; Jachowicz R
    Pharm Dev Technol; 2020 Nov; 25(9):1109-1117. PubMed ID: 32686538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solid-state characterization and dissolution properties of bicalutamide-beta-cyclodextrin inclusion complex.
    Patil AL; Pore YV; Kuchekar BS; Late SG
    Pharmazie; 2008 Apr; 63(4):282-5. PubMed ID: 18468387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physicochemical characterization of hot melt extruded bicalutamide-polyvinylpyrrolidone solid dispersions.
    Andrews GP; AbuDiak OA; Jones DS
    J Pharm Sci; 2010 Mar; 99(3):1322-35. PubMed ID: 19798757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formation of bicalutamide nanodispersion for dissolution rate enhancement.
    Li C; Li C; Le Y; Chen JF
    Int J Pharm; 2011 Feb; 404(1-2):257-63. PubMed ID: 21093558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and characterization of bicalutamide-poloxamer F68 solid dispersion systems.
    Sancheti PP; Vyas VM; Shah M; Karekar P; Pore YV
    Pharmazie; 2008 Aug; 63(8):571-5. PubMed ID: 18771004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanosized bicalutamide and its molecular structure in solvents.
    Le Y; Ji H; Chen JF; Shen Z; Yun J; Pu M
    Int J Pharm; 2009 Mar; 370(1-2):175-80. PubMed ID: 19101616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving the wetting and dissolution of ibuprofen using solventless co-milling.
    Varghese S; Ghoroi C
    Int J Pharm; 2017 Nov; 533(1):145-155. PubMed ID: 28951348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving the physicochemical properties of bicalutamide by complex formation with bovine serum albumin.
    Yang C; Di P; Fu J; Xiong H; Jing Q; Ren G; Tang Y; Zheng W; Liu G; Ren F
    Eur J Pharm Sci; 2017 Aug; 106():381-392. PubMed ID: 28571783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-crystallization for enhanced dissolution rate of bicalutamide: preparation and evaluation of rapidly disintegrating tablets.
    Essa EA; Elbasuony AR; Abdelaziz AE; El Maghraby GM
    Drug Dev Ind Pharm; 2019 Aug; 45(8):1215-1223. PubMed ID: 30661420
    [No Abstract]   [Full Text] [Related]  

  • 12. Characteristics of bicalutamide solid dispersions and improvement of the dissolution.
    Ren F; Jing Q; Tang Y; Shen Y; Chen J; Gao F; Cui J
    Drug Dev Ind Pharm; 2006 Sep; 32(8):967-72. PubMed ID: 16954109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spherical agglomeration to improve dissolution and micromeritic properties of an anticancer drug, Bicalutamide.
    Dalvadi H; Parmar K; Yadav S
    Drug Dev Ind Pharm; 2019 Jun; 45(6):968-980. PubMed ID: 30784326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone.
    Caron V; Tajber L; Corrigan OI; Healy AM
    Mol Pharm; 2011 Apr; 8(2):532-42. PubMed ID: 21323367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring the Dissolution Mechanisms of Amorphous Bicalutamide Solid Dispersions via Real-Time Raman Mapping.
    Tres F; Patient JD; Williams PM; Treacher K; Booth J; Hughes LP; Wren SA; Aylott JW; Burley JC
    Mol Pharm; 2015 May; 12(5):1512-22. PubMed ID: 25872658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding the performance of melt-extruded poly(ethylene oxide)-bicalutamide solid dispersions: characterisation of microstructural properties using thermal, spectroscopic and drug release methods.
    Abu-Diak OA; Jones DS; Andrews GP
    J Pharm Sci; 2012 Jan; 101(1):200-13. PubMed ID: 21905037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Disorder of Bicalutamide-Amorphous Solid Dispersions Obtained by Solvent Methods.
    Szafraniec J; Antosik A; Knapik-Kowalczuk J; Gawlak K; Kurek M; Szlęk J; Jamróz W; Paluch M; Jachowicz R
    Pharmaceutics; 2018 Oct; 10(4):. PubMed ID: 30340413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formation and characterization of solid dispersions of piroxicam and polyvinylpyrrolidone using spray drying and precipitation with compressed antisolvent.
    Wu K; Li J; Wang W; Winstead DA
    J Pharm Sci; 2009 Jul; 98(7):2422-31. PubMed ID: 18972575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of bicalutamide-loaded PLGA nanoparticles: preparation, characterization and in-vitro evaluation for the treatment of prostate cancer.
    Ray S; Ghosh Ray S; Mandal S
    Artif Cells Nanomed Biotechnol; 2017 Aug; 45(5):944-954. PubMed ID: 27327352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How can we improve the physical stability of co-amorphous system containing flutamide and bicalutamide? The case of ternary amorphous solid dispersions.
    Pacult J; Rams-Baron M; Chmiel K; Jurkiewicz K; Antosik A; Szafraniec J; Kurek M; Jachowicz R; Paluch M
    Eur J Pharm Sci; 2019 Aug; 136():104947. PubMed ID: 31170526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.